QualityStocksNewsBreaks Archives - Page 532 of 1474

WednesdayFeb 16, 2022 1:47 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Evolution to Commercial Sales to Health and Wellness Market Featured in Research Report

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, was featured in a report published by Edison Group, a leading research and investor relations consultancy. According to the piece, InMed achieved Q222 financial results that reflect its evolution from a pure-play biotech firm to one with commercial sales to the health and wellness market, with revenues of $0.3 million, all cannabichromene (“CBC”). “As of January, it also began selling cannabicitran (‘CBT’) to the health and wellness market,” notes the report. “The now-completed BayMedica acquisition boosts its product portfolio for rare cannabinoids and rounds…

WednesdayFeb 16, 2022 1:26 pm

QualityStocksNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Adds Novel Molecule to Family of Psilocin Analogs

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, has included a novel molecule — MYCO-005 — which has potential for heart-safe microdose enabling properties, to its psilocin analogs. The company submitted a patent application covering multiple families of psilocin analogs late last year, noting that these second-generation molecules address delivery and stability concerns with the first-generation compounds. According to the company, its research findings show the potential for a psilocin analog that may be considered a heart-safe microdose drug, which is a substance consumed at a low enough…

WednesdayFeb 16, 2022 12:48 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC), Artos Ltd. Enter Agreement to Expand Offering of Cannabis Products for Israeli Market

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has announced its entry into an agreement with Artos Ltd. to sell approximately 3,600 kg of dried high-THC cannabis flower to Israel from its Cosechemos cultivation facility. Through the agreement, Flora seeks to establish a partnership with the Artos team to expand their offering of cannabis products for the Israeli market to also include oils and, when regulations permit, finished THC and CBD consumer products. The export of the high-THC product is pending the dried-flower checklist from the Colombian government from the 2021 cannabis law…

WednesdayFeb 16, 2022 12:42 pm

QualityStocksNewsBreaks – GreenBox POS (NASDAQ: GBOX) Partners with Cross River to Launch First Banking-as-a-Service Initiative

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, announced that it has entered into a licensing agreement with Cross River, a respected technology-driven infrastructure provider that offers embedded financial solutions. GBOX’s partnership with Cross River allows the fintech pioneer to launch its first banking-as-a-service initiative and position itself as strong financial technology-driven brands. Leveraging Cross River’s infrastructure and access to the payment rails enables GreenBox to open custodial, reserve and operating accounts for its customers, who can then manage those accounts with a full suite of tools, also powered by Cross River. According to the announcement, the new…

WednesdayFeb 16, 2022 12:10 pm

QualityStocksNewsBreaks – DigiMax Global Inc. (CSE: DIGI) (OTC: DBKSF) Announces Global Launch of CryptoHawk AI Mobile App

DigiMax Global (CSE: DIGI) (OTC: DBKSF), a company that provides artificial intelligence (“AI”) and cryptocurrency technology solutions, today announced that it has launched its new mobile app version of CryptoHawk AI on Apple and Google App stores around the globe. As one of the most comprehensive crypto investing insight tools available in the market today, free access to CryptoHawk AI insight means that anyone on the planet can access AI to help them make better investing decisions. “CryptoHawk AI is a game changer that elevates cryptocurrency investing opportunities to a larger population,” said DigiMax CTO Thierry Hubert. “Whether cryptocurrency prices…

WednesdayFeb 16, 2022 11:35 am

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) CEO to Participate in Fireside Chat at Aegis Virtual Conference

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that its CEO Doug Drysdale will participate in a fireside chat at the Aegis Virtual Conference. The event will span three days, from Feb 23-25, 2022, with Drysdale’s presentation scheduled to begin at 2 p.m. ET on Thursday, Feb. 24. Interested parties should visit https://ibn.fm/eqPBg to listen to the event and access the webcast. An archived webcast will also be available on the company’s investor relations website. To view the full press release, visit https://ibn.fm/qjBqv About Cybin Inc. Cybin is a leading ethical…

WednesdayFeb 16, 2022 11:17 am

QualityStocksNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) CEO Featured in Recent Power Play Interview

Eat Well Group (CSE: EWG) (OTC: EWGFF) CEO Marc Aneed was interviewed during a recent Power Play by the Market Herald interview. Interviews for the Power Play by the Market Herald spotlight interviews with company executives about their latest news, and in this case, Power Play host Shoran Devi sat down with Aneed to talk about the company’s recent private placement. During the interview, Aneed explained that Eat Well Group has closed a nonbrokered private placement with Nurture Healthy Food LLP for gross proceeds of more than $5 million. As part of the private placement, Eat Well issued 6,690,666 units…

TuesdayFeb 15, 2022 3:19 pm

QualityStocksNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) Distinctive with Phased Approach to Novel Therapeutics Development

Mydecine (NEO: MYCO) (OTC: MYCOF), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, was featured in a recent Bell2Bell Podcast episode in which its co-founder, chairman and CEO Josh Bartch shared the company’s goals for the new year. Of note was Mydecine’s phased approach, which entails understanding the imperfections of initial formulations and then improving aspects such as the nature of half-life, controllability delivery time, onset time, anxiety associated with different molecules, etc., in order to make them more effective. This approach has set the company apart from its peers. A…

TuesdayFeb 15, 2022 1:25 pm

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) CEO Featured in Latest Stock2Me Podcast Episode

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a Canadian-based, growth-stage company committed to providing commercially viable and sustainable, cradle-to-cradle, clean-energy solutions, has announced that CEO Ian Clifford appears in the most recent episode of the Stock2Me podcast. The podcast comes from InvestorBrandNetwork (“IBN”), a multifaceted communications organization, and interviews individuals who are actively revolutionizing age-old business practices within their respective markets. During the interview, Clifford talked about FuelPositive’s rapid development in 2021 and the first part of 2022 as the company works to change the landscape surrounding ammonia production. Clifford and podcast host Stuart Smith also discussed the company’s focus on sustainability.…

TuesdayFeb 15, 2022 1:19 pm

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN), The Chopra Foundation Partner to Uncover Potential of Psychedelic Therapies in Mental Health

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” has entered a strategic partnership with The Chopra Foundation, a not-for-profit organization founded by Dr. Deepak Chopra, dedicated to improving health and well-being. Under the collaboration, The Chopra Foundation is working closely with Cybin to support education and awareness about its groundbreaking research to harness the potential of psychedelic therapies in mental health. Emerging research shows the potential for psychedelic-assisted therapy to improve the quality of life for people suffering with mental illnesses, including those specific indications that Cybin is targeting, such as major depressive…

Site Search

Company Search

Category: QualityStocksNewsBreaks